An experimental and modelling study of the electrochemical oxidation of pharmaceuticals using a boron-doped diamond anode

[Display omitted] •A mathematical model for electroxidation of target pharmaceuticals is proposed.•Two oxidation pathways are considered such as transfer of electrons and oxygen atoms.•The model is validated by experiments using solutions containing one or two organics.•A gain of electrolysis time of 50% was obtained with sulfate in the solution. This paper deals with an experimental and modelling study on the electrochemical oxidation of refractory pharmaceuticals using a boron-doped diamond (BDD) anode. Different parameters have been investigated, such as the role of salts (sulfates), the presence of other organics, and the influence of applied current intensity. Ciprofloxacin (CIP), Sulfamethoxazole (SMX) and Salbutamol (SALBU) were used for models of pharmaceuticals, and urea as a model for a common organic. The complete removal of pharmaceuticals was observed in all electrolyses under galvanostatic conditions. The presence of common organic waste or other pharmaceutical has no significant impact on the degradation of the CIP target molecule. A mathematical model predicting the temporal concentration variation of organics with electroxidation time has been developed. In this model, different oxidation pathways have been considered: the transfer of electrons (direct oxidation) or of oxygen atoms via the reaction with either hydroxyl radicals or/and with strong electrogenerated oxidants. Excellent correlation with experiments is obtained under all experimental conditions.